HR 3626 IH
107th CONGRESS
2d Session
H. R. 3626
To amend title XVIII of the Social Security Act to provide for an
outpatient prescription drug benefit under the Medicare Program.
IN THE HOUSE OF REPRESENTATIVES
January 24, 2002
Mrs. EMERSON (for herself and Mr. ROSS) introduced the following bill; which
was referred to the Committee on Energy and Commerce, and in addition to the
Committee on Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall within the
jurisdiction of the committee concerned
A BILL
To amend title XVIII of the Social Security Act to provide for an
outpatient prescription drug benefit under the Medicare Program.
Be it enacted by the Senate and House of Representatives of the United
States of America in Congress assembled,
SECTION 1. SHORT TITLE; FINDINGS.
(a) SHORT TITLE- This Act may be cited as the `Medicare Drug and Service
Coverage Act of 2002'.
(b) FINDINGS- Congress makes the following findings:
(1) It is important for seniors to have access to prescription drugs for
life and health. Prescription drugs are an important part of medical
therapy, but medicare does not have a voluntary prescription drug benefit
for seniors who need and want drug coverage.
(2) A comprehensive prescription drug benefit program for seniors would
help assure that seniors have access to necessary prescription drugs and
medication therapy management services, which are among the most
cost-effective medical interventions available in the health care
system.
(3) Seniors use more pharmaceuticals than any other population group,
and are in greater need of medication therapy management services to assist
them in proper medication utilization. These services will help reduce the
chance for adverse medication events, which result in increased medicare
spending for hospitalizations, nursing home stays, emergency room visits,
and physician office visits.
(4) A new prescription drug benefit for seniors should be structured so
that seniors have access to the distribution method of their choice without
any form of economic or other inducement to use an alternative distribution
system.
(5) To assure appropriate and meaningful cost controls under the
program, and in order to have their drugs covered, manufacturers should be
required to contribute to cost reductions in the medicare program.
SEC. 2. PRESCRIPTION DRUG BENEFIT PROGRAM.
(a) IN GENERAL- Title XVIII of the Social Security Act is amended--
(1) by redesignating part D as part E; and
(2) by inserting after part C the following new part:
`Part D--Outpatient Prescription Drug Benefit Program
`OUTPATIENT PRESCRIPTION DRUG BENEFIT PROGRAM ESTABLISHED
`SEC. 1860. There is established a voluntary prescription drug benefit
program to provide covered outpatient drugs and medication therapy management
services in accordance with the provisions of this part for beneficiaries who
elect to enroll under such program, to be financed with contributions from
funds appropriated by the Federal Government and premiums collected from
participating beneficiaries.
`SCOPE OF BENEFITS
`SEC. 1860A. (a) COVERED OUTPATIENT PRESCRIPTION DRUGS AND ASSOCIATED
SERVICES-
`(1) IN GENERAL- The benefits provided to a beneficiary under this part
shall consist of payments made in accordance with the provisions of this
part for the following services furnished by any pharmacy provider (as
defined in section 1860I(e):
`(A) PRESCRIPTION DRUGS- Covered outpatient prescription drugs, as
specified in subsection (b).
`(B) MEDICATION PREPARATION SERVICES- Covered medication preparation
services, as specified in subsection (c).
`(C) MEDICATION THERAPY MANAGEMENT SERVICES- Covered medication
therapy management services, as specified in subsection(d).
`(2) WILLING PHARMACY PROVIDERS- Any pharmacy provider that is
authorized by the applicable State agency to engage in the practice of
pharmacy may participate in the program established under this part.
`(b) COVERED OUTPATIENT PRESCRIPTION DRUGS-
`(1) IN GENERAL- Subject to paragraph (2), benefits under this part for
outpatient prescription drugs means, subject to section 1860B, payment for
all prescribed drugs within the meaning of the term covered outpatient
prescription drugs, as defined in section 1860I(a).
`(2) AVOIDANCE OF DUPLICATE PAYMENT UNDER MEDICARE- Payment under
paragraph (1) for covered outpatient prescription drugs may only be made,
with respect to such drugs for which payment may be made under part A or B,
only if benefits under part A or part B for such drugs have been
exhausted.
`(c) COVERED MEDICATION PREPARATION SERVICES- Covered medication
preparation services, for purposes of this part, means services provided by
pharmacy providers involving prescription drug compounding, the provision of
special packaging, and such other services involved in the preparation and
delivery of prescription drugs as the Secretary may prescribe.
`(d) COVERED MEDICATION THERAPY MANAGEMENT SERVICES-
`(1) IN GENERAL- Covered medication therapy management services
means--
`(A) services or programs furnished by a pharmacy provider which are
designed--
`(i) to assure that medications are used appropriately by
beneficiaries;
`(ii) to enhance beneficiaries' understanding of the appropriate use
of medications;
`(iii) to increase beneficiaries' compliance with prescription
medication regimens;
`(iv) to reduce the risk of potential adverse events associated with
medications; and
`(v) to reduce the need for other costly medical services through
better management of medication therapy; and
`(B) services provided in collaboration with physicians, pharmacists,
and other health care professionals when necessary, involving case
management, disease management, patient training and education, medication
refill reminders, medication therapy problem resolution, laboratory
testing conducted to monitor medication therapy, other services that
enhance the use of prescription medications, and such other professional
services consistent with the scope of the practice of pharmacy as defined
by applicable State law or regulation.
`(2) PROGRAM OPERATION- The program established under this subsection
will--
`(A) identify and provide medication therapy management services to
beneficiaries at risk for potential medication problems, such as
beneficiaries taking multiple medications and beneficiaries with complex
or chronic medical conditions;
`(B) be developed and structured in cooperation with organizations
representing pharmacy providers, including identifying those medication
therapy management services that will be provided, as well as payment
mechanisms for such services;
`(C) structure and update payments to reflect the resources and time
involved in the provision of such services, the level of risk associated
with the use of particular medications, and the health status of
beneficiaries to whom medication therapy management services are provided;
and
`(D) provide for ongoing evaluation and documentation of these
services in improving quality of care and reducing health care
costs.
`PAYMENT OF BENEFITS; BENEFIT LIMITS; BENEFICIARY COPAY
`SEC. 1860B. (a) ESTABLISHMENT OF ACCOUNT- There is established within the
Supplementary Medical Insurance Trust Fund an account to be known as the
Prescription Drug Benefit Insurance Account (hereinafter in this part referred
to as the `Account').
`(b) PAYMENT OF BENEFITS- Subject to the succeeding provisions of this
section, there shall be paid from the Account to a pharmacy provider that
furnishes services for which payment may be made under this part to an
individual who is enrolled under this part an amount, for each such service,
equal to the lesser of--
`(1) the reasonable charges for the benefits, as determined under
section 1860G; or
`(2) the pharmacy provider's customary charges with respect to such
benefits.
`(c) ANNUAL DEDUCTIBLE- Before applying subsection (b) with respect to
expenses incurred by an individual enrolled under this part during any
calendar year, the total amount of the expenses incurred by such individual
during such year (which would, except for this subsection, constitute incurred
expenses from which benefits payable under subsection (b) are determinable)
shall be reduced by a deductible of $250.
`(1) IN GENERAL- Subject to paragraphs (3) and (4), the amount payable
for services for which payment may be made under this part furnished an
individual enrolled under this part shall be reduced by a coinsurance amount
equal to established under paragraph (2).
`(2) ESTABLISHING ANNUAL COINSURANCE PERCENTAGE- Each year the Secretary
shall, with the advice of the Medicare Prescription Drug Benefit Advisory
Commission established in section 1860H, determine and promulgate a
coinsurance amount (as a percentage of the benefits provided) that qualified
beneficiaries pay with benefits covered under this program for the next
calendar year and in accordance with the limitations of this
subsection.
`(3) MAXIMUM COINSURANCE- The coinsurance established in paragraph (2)
may not exceed 20 percent.
`(4) LIMITS ON VARYING COINSURANCE AMOUNTS- The Secretary may not vary
the coinsurance amounts or make any differentiation of scope or quantity of
benefits coverage provided based on the method of providing the
services.
`PROCEDURE FOR PAYMENT OF CLAIMS
`SEC. 1860C. Payment for services described in section 1860A may be made
only to pharmacy providers and only if a claim is filed for such payment in
such form and manner as the Secretary may by regulation require. In no case
may payment be made later than 12 months following the year in which such
services are furnished.
`ELIGIBILITY AND ENROLLMENT
`SEC. 1860D. Every individual who, during or after 2003, is entitled to
hospital insurance benefits under part A and is enrolled in part B shall be
eligible to enroll in the program under this part in such form and manner as
the Secretary may require by regulation.
`PREMIUM FEES AND PAYMENT
`SEC. 1860E. (a) ANNUAL ESTABLISHMENT OF PREMIUM AMOUNT- Each year the
Secretary shall, with the advice of the Medicare Prescription Drug Benefit
Advisory Commission established in section 1860H, determine and promulgate a
monthly premium for beneficiaries who enroll under this part, taking into
account the total amount of payments expected to be made from Account for
furnishing services under this part for the next calendar year and in
accordance with the provisions of this section.
`(b) PAYMENT OF PREMIUMS- An individual enrolled in the program under this
part shall pay the premium established under subsection (a) to the Secretary
at such times and in such manner as the Secretary shall by regulation
require.
`(c) DEPOSIT OF FUNDS- Amounts paid to the Secretary under subsection (a)
shall be deposited in the Treasury to the credit of the Account.
`ADMINISTRATION OF BENEFITS THROUGH CARRIERS
`SEC. 1860F. (a) IN GENERAL- The Secretary shall contract with carriers
designated in accordance with subsection (d), based on a competitive bid,
fixed fee per transaction basis, to perform some or all of the following
administrative functions:
`(1) PROCESS AND ADJUDICATE CLAIMS- The carrier shall receive, process,
and make payment for claims to pharmacy providers through an online, real
time claims adjudication system that conforms to current industry standards,
and shall disburse and account for funds in making payments to pharmacy
providers under this part.
`(2) COMMUNICATE INFORMATION- The carrier shall serve as a channel of
communication of eligibility and coverage information to beneficiaries and
pharmacy providers.
`(3) QUALITY ASSURANCE- The carrier shall provide the information and
computer system support, either directly or through a contract with an
outside entity, for the pharmacy provider to conduct a drug utilization
review program conforming to the standards established by section
1927(g)(2), with modifications as the Secretary determines by regulation to
be appropriate.
`(4) PROTECTION AGAINST FRAUD AND ABUSE- The carrier shall conduct
activities to control fraud, abuse, and waste in accordance with regulations
promulgated by the Secretary.
`(5) COLLECTION OF PAYMENTS- The carrier shall collect payments from
participating pharmaceutical manufacturers as specified in subsection
(e).
`(b) LIMITS ON CARRIER FUNCTION- The Secretary shall not contract with
carriers--
`(1) to make determinations of the rates and amounts of payments to be
made to pharmacy providers under this part;
`(2) to make determinations of any limitations on covered benefits, such
as the nature, scope, choice, or amount of benefits available, as referred
to in section 1860A;
`(3) to make determinations of pharmacy provider eligibility;
`(4) to carry out any tasks beyond the administrative and ministerial
duties authorized by this section, including aggregate purchasing; or
`(5) to practice medicine or pharmacy.
`(c) REQUIREMENTS FOR PAYING CLAIMS AND GRIEVANCE PROCEDURES- Each
contract under this section that provides for the disbursement of funds as
described in subsection (a)(1) shall provide that--
`(1) payment shall be issued, mailed, or otherwise transmitted for
claims submitted under this part in accordance with the procedures
established by section 1842(c); and
`(2) each carrier shall have in place such procedures as the Secretary
shall specify for hearing and resolving grievances brought by enrolled
beneficiaries against the carrier or pharmacy provider and the pharmacy
provider against the carrier concerning benefits under this part.
`(d) ELIGIBLE ENTITIES- Each carrier responsible for administering the
program established under this part shall meet at least the following
criteria:
`(1) PERFORMANCE CAPABILITY- The entity shall have sufficient expertise,
personnel, and resources to perform the contracted benefit
administrations.
`(2) PERFORMANCE RATING- The entity shall be subject to such review as
required by the Secretary, both prior to issuing a contract under this part
and in review of performance administering contracts under this part.
`(3) FINANCIAL INTEGRITY- The entity and its officers, directors,
agents, and managing employees shall have a satisfactory record of
professional competence and professional and financial integrity, and the
entity shall have adequate financial resources to perform services under the
contract without risk of insolvency.
`(4) CAPABILITY TO MAINTAIN RECORDS- The entity shall have systems to
maintain adequate records and afford the Secretary access to such records
(including for audit purposes).
`(5) COMPLIANCE WITH INDUSTRY STANDARDS- The entity shall comply with
standards adopted by the National Council on Prescription Drug Programs for
uniform identification cards, telecommunication standards, and drug
utilization review messaging.
`(6) COST AND PRICING DATA- The entity shall submit to the Secretary as
part of its bid submission all relevant cost and pricing data, including all
fees charged by the entity for performing the administrative functions
pursuant to any competitively bid contract awarded to the carrier under this
section, plus any and all administrative fees or other payments received by
the entity from drug manufacturers pursuant to the contract award.
`(7) CAPABILITY TO GENERATE REPORTS- The entity shall have systems to
make such reports and submissions of financial and utilization data as the
Secretary may require, including reports describing the nature and type of
direct and indirect manufacturers' payments received by the carrier,
assurance that payments made to pharmacy providers are based on such
standards as the Secretary may prescribe, and any other types of
administrative or claims processing fees received by the carrier.
`(e) MANUFACTURER PAYMENTS-
`(1) IN GENERAL- The Secretary shall only make payment under this part
for innovator multiple source drugs or single source drugs (as defined in
clauses (ii) and (iv), respectively, of section 1927(k)(7)(A)) for which
payment may be made
under this part of a manufacturer if that manufacturer has entered into and
has in effect an agreement with the Secretary that requires the manufacturer to
make periodic payments in the amount described in this subsection. A payment
agreement shall be effective for an initial period of not less than 1 year and
shall be automatically renewed for a period of not less than 1 year.
`(A) IN GENERAL- The payment amount for a covered outpatient
prescription drug furnished under this part shall be equal to not less
than the sum of the basic rebate amount (determined under subparagraph
(B)) for each dosage form and strength of such drug increased by the
amount of the inflation adjustment rebate (determined under subparagraph
(C)) for each dosage form and strength of such drug.
`(B) BASIC REBATE AMOUNT- The basic rebate amount shall be equal to
the product of the total number of units of each dosage form and strength
paid for by the carrier in the payment period (as defined in section
1927(b)), and the average manufacturers' price (as defined in section
1860I) for the quarter for the dosage form and strength of the covered
outpatient drug minus not less than 18 percent of the average
manufacturers' price for the quarter, or such amount as determined by the
Secretary through negotiations with the manufacturer of such
drug.
`(C) INFLATION ADJUSTMENT AMOUNT- The amount of the basic rebate
payment shall be increased by an amount equal to the product of the number
of units of each dosage form and strength paid for by the carrier in the
payment period and the amount by which the average manufacturers' price
for such drug and dosage form and strength for the calendar quarter
increased in excess of the percentage by which the consumer price index
for all urban consumers increased during the calendar quarter.
`(3) CARRIER RESPONSIBILITY- The carrier shall report to each
manufacturer not later than 60 days after the end of each payment period and
in a form consistent with a standard reporting format established by the
Secretary, information on the total number of units of each dosage form and
strength and package size of each covered outpatient drug dispensed in the
quarter for which payment was made under the plan during the period, and
shall promptly transmit a copy of such report to the Secretary.
`(4) MANUFACTURER RESPONSIBILITY- The manufacturer shall remit payments
to the Secretary through the carrier not later than 30 days after receiving
information from the carrier on the total number of units of each dosage
form and strength of the manufacturers' drugs paid for by the carrier in the
quarter.
`(5) COLLECTION OF PAYMENTS- The Secretary shall deposit the payments
collected under this subsection from manufacturers in the Account, and shall
use the payments to reduce the premiums paid by beneficiaries for the
purpose of providing the prescription drug benefit.
`PHARMACY PROVIDER ELIGIBILITY AND PAYMENT AMOUNTS
`SEC. 1860G. (a) IN GENERAL- Any pharmacy provider that meets the
requirements of this section shall be eligible to enter into an agreement with
the Secretary to furnish covered benefits to enrolled beneficiaries.
`(b) TERMS OF AGREEMENT- An agreement under this section shall include the
following terms and requirements:
`(1) LICENSING- The pharmacy provider shall meet (and throughout the
contract period will continue to meet) all applicable Federal, State, and
local licensing requirements.
`(2) PERFORMANCE STANDARDS- The pharmacy provider shall comply with
quality assurance standards applicable to pharmacists under section
1927(g).
`(3) PAYMENT- The Secretary shall, after consultation with the Medicare
Prescription Drug Benefit Advisory Commission established in section 1860H,
establish payment rates to--
`(A) pharmacy providers that--
`(i) are reasonable and adequate to cover all direct and indirect
costs of furnishing the items and services covered by this part, and a
reasonable return;
`(ii) are sufficient to enlist enough pharmacy providers to ensure
that items and services covered under this part are available to
beneficiaries at least to the extent that such items and services are
available to the general public;
`(iii) do not vary based on the size or corporate structure of the
pharmacy provider or factors commonly associated with the size of the
provider, such as prescription volume;
`(iv) provide appropriate incentives for dispensing lower cost
multiple source prescription drugs; and
`(v) recognize and provide appropriate payment incentives for
pharmacy providers located in rural and underserved areas (as the
Secretary may define by regulation); and
`(B) carriers that reflect the administrative costs of providing
administration of the prescription drug benefit as specified under section
1860F.
`MEDICARE PRESCRIPTION DRUG BENEFIT ADVISORY COMMISSION
`SEC. 1860H. (a) ESTABLISHMENT- There is established the Medicare
Prescription Drug Benefit Advisory Commission.
`(b) COMPOSITION- The Commission, appointed by the Secretary, shall
consist of an equal number of actively practicing physicians, consumers, and
actively practicing pharmacists. Other individuals may advise the Commission
as necessary, but may not participate as Commission members.
`(1) CONSULTATION WITH SECRETARY- The Medicare Prescription Drug Benefit
Advisory Commission shall consult with the Secretary as required by this
part.
`(2) REVIEW OF PAYMENT POLICIES AND ANNUAL REPORTS- The Medicare
Prescription Drug Benefit Advisory Commission shall--
`(A) review payment and eligibility policies under this part and make
recommendations to Congress concerning such payment policies;
`(B) review the impact on cost and quality of care of medication
therapy management services; and
`(C) by not later than May 1 of each year (beginning in 2004), submit
a report to Congress containing the results of such reviews and
recommendations concerning such policies.
`DEFINITIONS
`SEC. 1860I. In this part:
`(a) COVERED OUTPATIENT PRESCRIPTION DRUG-
`(1) IN GENERAL- Subject to paragraph (2), the term `covered outpatient
prescription drug' means--
`(A) a drug or biological that may be dispensed only upon a
prescription;
`(B) insulin certified under section 506 of the Federal Food, Drug,
and Cosmetic Act, and needles, syringes, and disposable pumps for the
administration of such insulin; and
`(C) such nonprescription drugs as defined under section 503 of the
Federal Food, Drug, and Cosmetic Act that are prescribed and determined
medically necessary by a physician or other health care provider licensed
by the State to prescribe medications.
`(2) EXCLUSION OF COSMETIC AGENTS AND FERTILITY AGENTS- Such term does
not include medications or classes of outpatient prescription drugs
described in subparagraphs (B) and (C) of section 1927(d)(2).
`(b) AVERAGE MANUFACTURERS' PRICE- The term `average manufacturers' price'
means, with respect to a prescription drug of a manufacturer provided under
this part for a calendar quarter, the average unit price paid to the
manufacturer by wholesalers for drugs distributed to the retail pharmacy class
of trade (excluding direct sales to hospitals, health maintenance
organizations, and wholesalers where the drug is relabeled under the
distributor's national drug code.) Average manufacturers' price includes cash
discounts allowed and all other price reductions that reduce the actual price
paid.
`(c) CARRIER- The term `carrier' means the entity responsible for
administering the prescription drug benefit program under this part. A carrier
may be a prescription claims processing vendor, wholesale and community
pharmacy delivery system, health care provider, insurer, or any other type of
entity as the Secretary may specify.
`(d) PHARMACY PROVIDER- The term `pharmacy provider' means a pharmacist or
pharmacy that--
`(1) is authorized by applicable State agencies to engage in the
practice of pharmacy;
`(2) meets the requirements of section 1860G; and
`(3) participates in the program under this part.'.
(b) CONFORMING AMENDMENTS-
(1) AMENDMENTS TO FEDERAL SUPPLEMENTARY HEALTH INSURANCE TRUST FUND-
Section 1841 of the Social Security Act (42 U.S.C. 1395t) is amended--
(A) in the last sentence of subsection (a)--
(i) by striking `and' after `section 201(i)(I)'; and
(ii) by inserting before the period the following: `, and such
amounts as may be deposited in, or appropriated to, the Prescription
Drug Benefit Insurance Account established by section 1860B';
and
(B) in subsection (g), by inserting after `by this part,' the
following: `the payments provided for under part D (in which case the
payments shall come from the Prescription Drug Benefit Insurance Account
in the Supplementary Medical Insurance Trust Fund),'.
(2) EXCLUSIONS FROM COVERAGE-
(A) APPLICATION TO PART D- Section 1862(a) of such Act (42 U.S.C.
1395y(a)) is amended in the matter preceding paragraph (1) by striking
`part A or part B' and inserting `part A, B, or D'.
(B) PRESCRIPTION MEDICATIONS NOT EXCLUDED FROM COVERAGE IF
APPROPRIATELY PRESCRIBED- Section 1862(a)(1) of such Act (42 U.S.C.
1395y(a)(1)) is amended--
(i) in subparagraph (H), by striking `and' at the end;
(ii) in subparagraph (I), by striking the semicolon at the end and
inserting `, and'; and
(iii) by adding at the end the following new
subparagraph:
`(J) in the case of prescription medications covered under part D,
which are not prescribed in accordance with such part;'.
(c) EFFECTIVE DATE- The amendments made by this section shall take effect
on the date of the enactment of this Act, and shall apply with respect to
benefits for prescription drugs furnished on or after January 1, 2003.
SEC. 3. GAO STUDY AND BIENNIAL REPORTS ON SAVINGS.
(a) ONGOING STUDY- The Comptroller General of the United States, in
consultation with the Medicare Prescription Drug Benefit Advisory Commission
established under section 1860H of the Social Security Act (as added by
section 2(a)), shall conduct an ongoing study and analysis of the prescription
drug benefit program under part D of the Social Security Act (as added by such
section), with an analysis of the savings to the medicare program resulting
from such drug benefit program, including savings to medicare parts A and B,
by reason of, for example, the reduction in the number or length of hospital
visits.
(b) REPORT- Not later than January 1, 2004, and every 2 years thereafter,
the Comptroller General of the United States shall submit to Congress a report
on the results of the study conducted under this section, together with any
recommendation for legislation determined to be appropriate as a result of
such study.
SEC. 4. AUTHORIZATION OF APPROPRIATIONS.
There are authorized to be appropriated from time to time, out of any
moneys in the Treasury not otherwise appropriated, to the Prescription Drug
Benefit Insurance Account within the Supplementary Medical Insurance Trust
Fund established under section 1841, an amount equal to the amount by which
the benefits and administrative costs of providing the benefits under this
part exceed the premiums collected under section 1860E.
END